-
公开(公告)号:US09000174B2
公开(公告)日:2015-04-07
申请号:US11665345
申请日:2005-10-14
申请人: Elfrida R. Benjamin , Zhengming Chen , Deyou Sha , Laykea Tafesse , Samuel F. Victory , John W. F. Whitehead
发明人: Elfrida R. Benjamin , Zhengming Chen , Deyou Sha , Laykea Tafesse , Samuel F. Victory , John W. F. Whitehead
IPC分类号: C07D211/58 , A61K31/4545 , A61K31/4468 , C07D401/06 , C07D211/96
CPC分类号: C07D401/06 , C07D211/58 , C07D211/96
摘要: The invention relates to piperidinyl compounds of Formula (I): or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R1-R3 and Z are defined as set forth in the specification. The invention is also directed to an assay useful for identifying such compounds as N-type calcium channel modulators or blockers. The invention is also directed to the compounds of Formula (I) and compounds identified by the above assay, and the use of such compounds to treat, prevent or ameliorate a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.
-
公开(公告)号:US08039636B2
公开(公告)日:2011-10-18
申请号:US12466797
申请日:2009-05-15
IPC分类号: C07D257/04 , C07D405/00
CPC分类号: C07D211/64 , C07D257/04 , C07D307/22 , C07D401/04
摘要: Methods, composition, and intermediates are disclosed that are useful for making 4-Tetrazolyl-4-phenylpiperidine Compounds according to Formula I, where Ar1 is —C3-C8 cycloalkyl, phenyl, naphthyl, anthryl, phenanthryl or -(5-7-membered) heteroaryl, each being unsubstituted or substituted with one or more R2 groups; Ar2 is phenyl, naphthyl, anthryl, phenanthryl or -(5-7-membered) heteroaryl, each being unsubstituted or substituted with one or more R2 groups; Z1 and Z2 are each independently a —(C1-C4 alkyl) group; R1 is —(CH2)nC(O)N(R3)(R4) where R3 and R4 are each independently H or —(C1-C4 alkyl); R2 is halogen, —C1-C3 alkyl, —O—(C1-C3 alkyl), —NH(C1-C3 alkyl) or —N(C1-C3 alkyl)2; n is an integer ranging from 1 to 4; m is an integer ranging from 0 to 4; and, in certain embodiments, the phenyl moiety attached to the 4-position of the piperidine ring of a compound according to Formula I can be optionally substituted with one or more R2 groups.
摘要翻译: 公开了可用于制备根据式I的4-四唑基-4-苯基哌啶化合物的方法,组合物和中间体,其中Ar 1是-C 3 -C 8环烷基,苯基,萘基,蒽基,菲基或 - (5-7-元) )杂芳基,各自为未取代的或被一个或多个R 2基团取代; Ar 2是苯基,萘基,蒽基,菲基或 - (5-7-元)杂芳基,各自是未取代的或被一个或多个R 2基团取代; Z 1和Z 2各自独立地为 - (C 1 -C 4烷基)基团; R1是 - (CH2)nC(O)N(R3)(R4)其中R3和R4各自独立地是H或 - (C1-C4烷基); R2是卤素,-C1-C3烷基,-O-(C1-C3烷基),-NH(C1-C3烷基)或-N(C1-C3烷基)2; n为1〜4的整数; m为0〜4的整数; 并且在某些实施方案中,连接到根据式I的化合物的哌啶环的4-位的苯基部分可以任选地被一个或多个R 2基团取代。
-
公开(公告)号:US5196534A
公开(公告)日:1993-03-23
申请号:US704099
申请日:1991-05-22
IPC分类号: C07B61/00 , C07D211/86 , C07D471/04
CPC分类号: C07D471/04 , C07D211/86
摘要: The invention relates to a process for the preparation of a compound of formula (I) ##STR1## wherein R represent a hydrogen atom or a methyl or ethyl group, which comprises cyclising a compound of formul (IV) ##STR2## Where R represents a hydrogen atom, the compound of formula (IV) may optionally be alkylated to produce a compound in whcich R is methyl or ethyl.The compound of formula (I) is useful as an intermediate in the preparation of 2,3,4,5-tetrahydro-2-[(imidazol-4(or 5)-yl)methyl]-1H-pyrido[4,3-b]indol-1-ones having 5-HT.sub.3 antagonist activity.
-
公开(公告)号:US07557219B2
公开(公告)日:2009-07-07
申请号:US11495221
申请日:2006-07-28
IPC分类号: C07D257/04 , A61K31/445
CPC分类号: C07D211/64 , C07D257/04 , C07D307/22 , C07D401/04
摘要: Methods, composition, and intermediates are disclosed that are useful for making 4-Tetrazolyl-4-phenylpiperidine Compounds according to Formula I, where Ar1 is —C3-C8 cycloalkyl, phenyl, naphthyl, anthryl, phenanthryl or -(5-7-membered) heteroaryl, each being unsubstituted or substituted with one or more R2 groups; Ar2 is phenyl, naphthyl, anthryl, phenanthryl or -(5-7-membered) heteroaryl, each being unsubstituted or substituted with one or more R2 groups; Z1 and Z2 are each independently a —(C1-C4 alkyl) group; R1 is —(CH2)nC(O)N(R3)(R4) where R3 and R4 are each independently H or —(C1-C4 alkyl); R2 is halogen, —C1-C3 alkyl, —O—(C1-C3 alkyl), —NH(C1-C3 alkyl) or —N(C1-C3 alkyl)2; n is an integer ranging from 1 to 4; m is an integer ranging from 0 to 4; and, in certain embodiments, the phenyl moiety attached to the 4-position of the piperidine ring of a compound according to Formula I can be optionally substituted with one or more R2 groups.
摘要翻译: 公开了可用于制备根据式I的4-四唑基-4-苯基哌啶化合物的方法,组合物和中间体,其中Ar 1是-C 3 -C 8环烷基,苯基,萘基,蒽基,菲基或 - (5-7-元) )杂芳基,各自为未取代的或被一个或多个R 2基团取代; Ar 2是苯基,萘基,蒽基,菲基或 - (5-7-元)杂芳基,各自是未取代的或被一个或多个R 2基团取代; Z 1和Z 2各自独立地为 - (C 1 -C 4烷基)基团; R1是 - (CH2)nC(O)N(R3)(R4)其中R3和R4各自独立地是H或 - (C1-C4烷基); R2是卤素,-C1-C3烷基,-O-(C1-C3烷基),-NH(C1-C3烷基)或-N(C1-C3烷基)2; n为1〜4的整数; m为0〜4的整数; 并且在某些实施方案中,连接到根据式I的化合物的哌啶环的4-位的苯基部分可以任选地被一个或多个R 2基团取代。
-
-
-